Clinical Trials Browser

Phase 2 × Neuroblastoma × Population Groups × Clear all

NCT00072358 2022-05-16

Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma

Phase 2 Completed

291 enrolled 7 charts

Neuroblastoma